Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
NCT05603715Phase 2Recruiting
- Sponsor
- University of Vermont Medical Center
- Start
- Aug 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyridostigmine in constipation, sponsored by University of Vermont Medical Center. Started Aug 2022; status: recruiting.
02
Drugs
pyridostigmine
03
Conditions
constipation
Beyond the preview
Go deeper on NCT05603715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05603715.